Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community.
JanBest of ASH 2016
Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma(...)
NovPre-ASH: What Myeloma Patients & Caregivers Need to Know
click on the image above to watch the teleconference (to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo) IMF’s Chairman of the Board Dr. Brian G.(...)
SepCAR T-Cell Therapy: What Patients & Caregivers Need to Know
Dr. Rafat Abonour (Indiana University – Simon Cancer Center) and Dr. Edward Stadtmauer (University of Pennsylvania). CAR T cells, or chimeric antigen receptor T cells, are part of a class of cancer(...)
MayLiving Well with Myeloma: What You Need to Know to Overcome Side Effects from Novel Therapies
Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN Cleveland Clinic Taussig Cancer Institute Multiple Myeloma Program Cleveland, OH Kevin Brigle, PhD, NP VCUHS Massey Cancer Center Richmond, VA
MarLiving Well with Myeloma: IMF's Expert Panel Answers Your Top Concerns
An IMF expert panel answers your top concerns. The panelists include Drs. Brian Durie, Rafat Abonour, and S. Vincent Rajkumar.
JanBest of ASH 2015: What Patients and Caregivers Need to Know
Join Dr. Brian G.M. Durie as he discusses the latest news from the 57th American Society of Hematology (ASH) Conference which recently convened in Orlando, FL on December 5-7th.